NCT00093288 - Major Depressive Disorder In The Elderly | Biotech Hunter

Enrollment

364

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions

Depressive Disorder, Major

Interventions

DRUG

bupropion XL

Trial Locations (16)

GSK Investigational Site, St Albans

GSK Investigational Site, Liège

GSK Investigational Site, New Farm

GSK Investigational Site, Everton Park

GSK Investigational Site, Caboolture

GSK Investigational Site, Mont-Godinne

GSK Investigational Site, Montignies-sur-Sambre

GSK Investigational Site, Mikkeli

GSK Investigational Site, Moscow

GSK Investigational Site, Moscow

GSK Investigational Site, Amersfoort

GSK Investigational Site, Grubbenvorst

GSK Investigational Site, Hilversum

GSK Investigational Site, Hoogvliet

GSK Investigational Site, Wildervank

GSK Investigational Site, Oslo